)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Kobayashi Pharmaceutical
Kobayashi Pharmaceutical (4967) investor relations material
Kobayashi Pharmaceutical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary8 May, 2026
Executive summary
Q1 consolidated net sales rose 3.2% year-over-year to ¥33.6 billion, with both domestic and international sales increasing as planned.
Operating income dropped 46.7% year-over-year to ¥1.3 billion, mainly due to a significant increase in advertising expenses following the resumption of advertising in July 2025.
Net income declined 36.2% year-over-year to ¥1.0 billion.
Comprehensive income improved to ¥2,357 million from a loss of ¥2,052 million in the prior year.
Extraordinary loss of ¥0.3 billion related to red yeast rice products was offset by gains from the sale of investment securities.
Financial highlights
Gross profit increased 4.5% year-over-year to ¥17.4 billion, with a margin of 51.8%.
Ordinary income fell 30.4% year-over-year to ¥1.6 billion.
EBITDA decreased 23.6% year-over-year to ¥3.6 billion.
Advertising expenses surged 186.2% year-over-year to ¥3.0 billion.
Basic earnings per share dropped to ¥13.95 from ¥21.86 year-over-year.
Outlook and guidance
Full-year forecast remains unchanged: net sales projected at ¥173.0 billion (+4.4%), operating income at ¥12.5 billion (-16.2%), and net income at ¥10.0 billion (+173.5%).
Dividend forecast raised to ¥106 per share.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Kobayashi Pharmaceutical
- Profits plunged on impairment and recall losses, but FY2026 net income is set for a strong rebound.4967
Q4 20259 Mar 2026 - Recall-related losses drove profit plunge, but international sales remained strong.4967Q2 202410 Feb 2026
- Sharp profit decline from recall and compensation costs, despite U.S. sales growth.4967Q3 202410 Feb 2026
- Product recall drives sharp profit decline; restructuring and quality investments planned.4967Q4 202410 Feb 2026
- Sales and profits fell in H1 FY2025, but net income rebounded and reforms support gradual recovery.4967Q2 202510 Feb 2026
- Sales and profits fell sharply on recall impact, but net income rose and guidance is unchanged.4967Q1 202510 Feb 2026
- Sales and profit fell YoY on recall costs, but net income rose; outlook and dividends unchanged.4967Q3 202510 Feb 2026
Next Kobayashi Pharmaceutical earnings date
Q2 20266 Aug, 2026
Kobayashi Pharmaceutical
Next Kobayashi Pharmaceutical earnings date
Q2 20266 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage